Cargando…

Glucose and Blood Pressure-Dependent Pathways–The Progression of Diabetic Kidney Disease

The major clinical associations with the progression of diabetic kidney disease (DKD) are glycemic control and systemic hypertension. Recent studies have continued to emphasize vasoactive hormone pathways including aldosterone and endothelin which suggest a key role for vasoconstrictor pathways in p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Devang M., Bose, Madhura, Cooper, Mark E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139394/ https://www.ncbi.nlm.nih.gov/pubmed/32210089 http://dx.doi.org/10.3390/ijms21062218

Ejemplares similares

Effects of glucose and blood pressure control on diabetic kidney disease in old patients with type 2 diabetes
por: Wu, Tzu-En, et al.
Publicado: (2014)

Central Blood Pressure and Chronic Kidney Disease Progression
por: Cohen, Debbie L., et al.
Publicado: (2011)

Different Combinations of Glucose Tolerance and Blood Pressure Status and Incident Diabetes, Hypertension, and Chronic Kidney Disease
por: Derakhshan, Arash, et al.
Publicado: (2016)

Blood Pressure and Chronic Kidney Disease Progression: An Updated Review
por: Habas, Elmukhtar, et al.
Publicado: (2022)

Progression of kidney disease in type 2 diabetes – beyond blood pressure control: an observational study
por: Leehey, David J, et al.
Publicado: (2005)

Arterial stiffness and kidney disease progression in the systolic blood pressure intervention trial
por: Nowak, Kristen L., et al.
Publicado: (2020)

Blood Pressure Control in Patients with Diabetic Kidney Disease
por: Kim, Yaeni, et al.
Publicado: (2022)

Evaluation of Serum Glucose and Kidney Disease Progression Among Patients With Diabetes
por: Jung, Hae Hyuk
Publicado: (2021)

Association of Time-Varying Blood Pressure With Chronic Kidney Disease Progression in Children
por: Reynolds, Ben Christopher, et al.
Publicado: (2020)

Dapagliflozin alleviates renal inflammation and protects against diabetic kidney diseases, both dependent and independent of blood glucose levels
por: Cai, Anxiang, et al.
Publicado: (2023)

Postoperative blood pressure deficit and acute kidney injury progression in vasopressor-dependent cardiovascular surgery patients
por: Saito, Shinjiro, et al.
Publicado: (2016)

Association of morning blood pressure surge with chronic kidney disease progression in patients with chronic kidney disease and hypertension
por: Liu, Xiang, et al.
Publicado: (2021)

Beyond Blood Glucose and Blood Pressure Control in Type 2 Diabetes: Alternative Management Strategies to Prevent the Development and Progression of CKD
por: Wright, Wendy L., et al.
Publicado: (2023)

The Body Mass Index, Blood Pressure, and Fasting Blood Glucose in Patients With Methamphetamine Dependence
por: Lv, Dezhao, et al.
Publicado: (2016)

Relation between Blood Pressure Management and Renal Effects of Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Patients with Chronic Kidney Disease
por: Kobayashi, Kazuo, et al.
Publicado: (2019)

Qualitative study of telemonitoring of blood glucose and blood pressure in type 2 diabetes
por: Hanley, Janet, et al.
Publicado: (2015)

Visit-to-visit variability in blood pressure and kidney disease progression in IgA nephropathy
por: Tang, Chen, et al.
Publicado: (2022)

Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes
por: Ruilope, Luis M., et al.
Publicado: (2022)

Effect of finerenone on ambulatory blood pressure in chronic kidney disease in type 2 diabetes
por: Agarwal, Rajiv, et al.
Publicado: (2023)

Ambulatory blood pressure monitoring-based analysis of long-term outcomes for kidney disease progression
por: Ida, Tomoharu, et al.
Publicado: (2019)

Reduced Blood Pressure Dipping Is A Risk Factor for the Progression of Chronic Kidney Disease in Children
por: Deja, Anna, et al.
Publicado: (2022)

Diabetic Kidney Disease: Much Progress, But Still More to Do
por: Molitch, Mark E.
Publicado: (2015)

Blood pressure reduction and RAAS inhibition in diabetic kidney disease: therapeutic potentials and limitations
por: Leoncini, Giovanna, et al.
Publicado: (2020)

Blood pressure and vascular determinants of glomerular filtration rate decline in diabetic kidney disease
por: Truscello, Luca, et al.
Publicado: (2023)

Pulse pressure and diabetes treatments: Blood pressure and pulse pressure difference among glucose lowering modality groups in type 2 diabetes
por: Alemi, Hamid, et al.
Publicado: (2018)

Short‐Term Systolic Blood Pressure Variability and Kidney Disease Progression in Patients With Chronic Kidney Disease: Results From C‐STRIDE
por: Wang, Qin, et al.
Publicado: (2020)

Glucose- and Non-Glucose-Induced Mitochondrial Dysfunction in Diabetic Kidney Disease
por: Ito, Marie, et al.
Publicado: (2022)

Ascorbic acid lowers central blood pressure and asymmetric dimethylarginine in chronic kidney disease
por: Gillis, Keith, et al.
Publicado: (2018)

Association of Glucose Metabolism and Blood Pressure during Pregnancy with Subsequent Maternal Blood Pressure
por: Maresh, M., et al.
Publicado: (2022)

The sodium–glucose cotransporter 2 inhibitor tofogliflozin prevents diabetic kidney disease progression in type 2 diabetic mice
por: Li, Zi, et al.
Publicado: (2020)

Research progress on multiple cell death pathways of podocytes in diabetic kidney disease
por: Yang, Can, et al.
Publicado: (2023)

Blood pressure control in patients with chronic kidney disease
por: Lee, Jee Young, et al.
Publicado: (2021)

Tight Blood Pressure Control in Chronic Kidney Disease
por: Gentile, Giorgio, et al.
Publicado: (2022)

Comparison of Circulating Biomarkers in Predicting Diabetic Kidney Disease Progression With Autoantibodies to Erythropoietin Receptor
por: Oshima, Megumi, et al.
Publicado: (2020)

What should the optimal blood pressure goal be in patients with diabetes mellitus or chronic kidney disease?
por: Aronow, Wilbert S.
Publicado: (2012)

Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control
por: Tremblay, Johanne, et al.
Publicado: (2021)

Effect of alcohol on blood glucose and antioxidant enzymes in the liver and kidney of diabetic rats
por: Shanmugam, K. R., et al.
Publicado: (2011)

Glucose Transporters in Diabetic Kidney Disease—Friends or Foes?
por: Wasik, Anita A., et al.
Publicado: (2018)

The Effects of Glucose-Lowering Therapies on Diabetic Kidney Disease
por: Agrawal, V., et al.
Publicado: (2015)

Slowing the Progression of Diabetic Kidney Disease
por: Blazek, Olivia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_67bhklrsnqpthrocjs68sd37cl